Description
Atezolizumab, marketed under the brand name TECENTRIQ, It is an prescription medication that has been approved atezolizumab as adjuvant therapy in patients with stage II to IIIA non-small cell lung cancer (NSCLC) whose tumors have programmed death-ligand 1 (PD-L1) expression on ≥ 1% of tumor cells (TC), as detected by an FDA-approved test. In October 15, 2021.
What is TECENTRIQ (atezolizumab) ?
TECENTRIQ (atezolizumab) injection, for intravenous use. U.S. Approval: 2016.
TECENTRIQ is a prescription medicine used to treat adults with: A type of bladder and urinary tract cancer called urothelial carcinoma. A type of lung cancer called non-small cell lung cancer (NSCLC). A type of breast cancer called triple-negative breast cancer (TNBC). A type of lung cancer called small cell lung cancer (SCLC).
How to order approved “TECENTRIQ (atezolizumab) for injection” Medicine?
TECENTRIQ (Atezolizumab) Injection is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing TECENTRIQ and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
